References
- Bardos T. J., Chmielewicz Z. F., Hebborn P. Structure-activity relationships of alkylating agents in cancer chemotherapy. Annals of the New York Academy of Sciences 1968; 163: 1006–1025
- Bardos T. J., Datta-Gupta N., Hebborn P., Triggle D. J. A study of comparative chemical and biological activities of alkylating agents. Journal of Medicinal Chemistry 1969; 8: 167–174
- Berges J., Peradejordi F. Theoretical studies on the reaction mechanism of cytotoxic aromatic nitrogen mustards. Molecular and Quantum Pharmacology, E. D. Bergmann, B. Pullman, D. Reidel. Dordrecht. 1974; 549–572
- Bingham R. C., Dewar M. J. S., Lo D. H. Ground states of molecules XXV. MINDO/3. Improved version of the MINDO semi-empirical SCF-MO method. Journal of the American Chemical Society 1975; 97: 1285–1293
- Boesen E., Davis W. Cytotoxic Drugs in the Treatment of Cancer. E. Arnold, London 1969; 65
- Carter S. K., Bakowski M. T., Hellmann K. Chemotherapy of Cancer. Wiley, New York 1977; 332–337
- Garcia-Blanco S., Perales A. The crystal structure of N, N-bis-2-chloroethyl-N', O-propylene phosphoric ester diamide (Endoxan). Acta Crystallographica 1972; B28: 2647–2652
- Leo A., Panthananickal A., Hansch C. A comparison of mutagenic and carcinogenic activities of aniline and mustards. Journal of Medicinal Chemistry 1981; 24: 859–864
- Mc Lean A., Newell D., Baker G. The metabolism of chlorambucil. Biochemical Pharmacology 1976; 25: 2331–2335
- Ollis J., James V. J. p-(Di-2-chloroethyl) aminophenyl butyric acid. Chlorambucil-C14H 19 Cl 2 NO 2. Crystal Structure Communications 1975; 4: 413–416
- Panthananickal A., Hansch C., Leo A. Structure-activity relationships in antitumor aniline mustards. Journal of Medicinal Chemistry 1978; 21: 16–26
- Panthananickal A., Hansch C., Leo A. Structure-activity relationship of aniline mustards acting against B-16 melanoma in mice. Journal of Medicinal Chemistry 1979; 22: 1267–1269
- Pratt W. B. Fundamentals of Chemotherapy. Oxford University Press, London 1979; 272, Ch. 10
- Ross W. C. J. The chemistry of cytotoxic alkylating agents. Advances in Cancer Research 1953; 1: 397–449
- Ross W. C. J. Biological Alkylating Agents. Butterworth, London 1962
- Ross W. C. J., Warwick G. P. Reduction of cytotoxic azo compounds by hydrazine and by the xanthine oxidase-xanthine system. Nature 1955; 176: 298–299
- Ross W. C. J., Warwick G. P., Roberts J. J. Aryl-2-halogenoalkylamines. Part XIV. Some compounds possessing latent cytotoxic activity. Journal of the Chemical Society 1955; 3110–3116